September 14, 2016
(Managed Care Magazine) – This hasn’t been the best of years for the pharmaceutical industry on Capitol Hill. Even with pro-business Republicans running the show in Congress, pharma executives could not avoid being dragged before the C-Span cameras repeatedly to defend the spiraling cost of drugs and some particularly egregious displays of hubris by certain individuals (e.g., “Pharma Bro” Martin Shkreli). The bad publicity — along with individual Americans’ sticker shock at their own prescriptions — has led most Americans, including some Republicans, to support some kind of government action to reduce drug prices.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.